How EGFR c-Met Antibodies Fight Cancer
EGFR c-Met bispecific antibodies represent a significant leap forward in oncology, offering new hope in combating complex cancer types by addressing resistance mechanisms and enhancing treatment efficacy. By simultaneously targeting the EGFR and c-Met pathways, these innovative therapies promise to improve outcomes in cases where traditional single-target treatments fall short. Dive into the evolving landscape […]
3 minute read